Integer Holdings (ITGR) EBT Growth (1y) (2011 - 2026)
Integer Holdings (ITGR) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 5.78% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -27.02% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 74.66% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 103.34% |
| 10 | Integer Holdings | 3.41 Bn | 3.40 Bn | 109.60 Mn | 256.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 256.56% |
| Dec 31, 2025 | 19.23% |
| Sep 26, 2025 | 5.91% |
| Jun 27, 2025 | 13.87% |
| Mar 28, 2025 | -152.33% |
| Dec 31, 2024 | 30.93% |
| Sep 27, 2024 | 30.59% |
| Jun 28, 2024 | 33.96% |
| Mar 29, 2024 | 55.27% |
| Dec 31, 2023 | 125.84% |
| Sep 29, 2023 | 95.60% |
| Jun 30, 2023 | 22.39% |
| Mar 31, 2023 | 15.09% |
| Dec 31, 2022 | -40.10% |
| Sep 30, 2022 | -26.72% |
| Jul 1, 2022 | -20.65% |
| Apr 1, 2022 | -44.35% |
| Dec 31, 2021 | 23.11% |
| Oct 1, 2021 | -26.11% |
| Jul 2, 2021 | 18,553.33% |